Artiva Biotherapeutics, Inc.
USD6.97
+0.10 (+1.46%)
CEO
Fred Aslan
IPO Date
2024-07-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.95
Prev. Close
$6.87
Day Low
$6.71
Day High
$7.44
52W Low
$1.47
52W High
$14.53
Market Cap
$0.17B
Volume
0.49M
| 347,222 |
| $11.52 |
| 19 May 2026 | Miralles Gines Diego | President & Head of R&D | A-Award | Acquired | 77,500 | $0.00 |
| 19 May 2026 | Miralles Gines Diego | President & Head of R&D | A-Award | Acquired | 232,500 | $9.22 |
| 19 May 2026 | Raymon Heather | SVP, Research and Development | S-Sale | Disposed | 3,095 | $9.01 |
| 19 May 2026 | Horan Christopher | Chief Tech Operations Officer | S-Sale | Disposed | 7,002 | $9.01 |
| 19 May 2026 | Bush Jennifer | COO, CLO, Compliance Officer | S-Sale | Disposed | 8,790 | $9.01 |
| 19 May 2026 | Banerjee Subhashis | Chief Medical Officer | S-Sale | Disposed | 7,037 | $9.01 |
| 19 May 2026 | Aslan Fred | director, officer: Chief Executive Officer | S-Sale | Disposed | 27,116 | $9.01 |
| 13 May 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 6,510,416 | $11.52 |